BIOSINO
BioSino
MORE
BIOSINO
BIOSINO
Started in 1973
Dedicated to Become a Globally Competitive IVD Company

BioSino Bio-Technology & Science Inc. is a high-tech listed company founded by the Institute of Biophysics, Chinese Academy of Sciences. It mainly engages in the research and development, production, sales, service and transformation of in-vitro diagnostic (IVD) products.

MORE
BIOSINO
Beautify Life with Technology

The company has established a complete series of biochemical detection product platforms, developing POCT, immunology, molecular, flow cytometry, and home self-testing + APP and other in-vitro diagnostic and precision medicine series of products and innovative service models, committed to creating comprehensive solutions for clinical diagnosis and companion diagnostics.

MORE
scroll down

About Us

BioSino Bio-Technology & Science Inc. (hereinafter referred to as BIOSINO) was established in 1988 and listed in Hong Kong in 2006 (stock code: HK8247). It is a high-tech enterprise founded by the Institute of Biophysics, Chinese Academy of Sciences, mainly engaged in the research and development, production, sales and service of in-vitro diagnostic (IVD) products. The history of the company's reagent production can be traced back to the three-link preparation group of the Institute of Biophysics in 1973. The company's development has always been guided by the needs of people's livelihood, actively promoting the development of the national IVD industry, building an independent innovation system combining production, learning, research and application, exploring the "internationalization, groupization, and complexization" business model, and constructing a "systematic, serialized, integrated, and intelligent" four-in-one full industrial chain to enhance core competitiveness and establish a certain influence in the industry. Since the launch of China's enzymatic single and double biochemical reagents, BIOSINO has accumulated a wealth of products over the years, establishing a complete biochemical detection series product platform, expanding immunology, molecular, flow cytometry and other in-vitro diagnostic series products, and is committed to creating a comprehensive clinical diagnosis solution. Currently, it has obtained approximately 270 registration certificates for in-vitro diagnostic reagent products, mainly covering twelve categories of biochemical testing items such as liver function, kidney function, blood lipids, cardiovascular, diabetes, and rheumatism. It is one of the domestic manufacturers with the most complete range of biochemical diagnostic reagent products.

Explore More

PRODUCTS

Products and Solutions

Committed to creating a comprehensive clinical diagnostic solution

Biochemical Products
Biochemical Products

Biochemical Products

Focused on biochemical diagnostic products for over 50 years.

More
Flow Cytometry Products
Flow Cytometry Products

Flow Cytometry Products

Providing a complete flow cytometry solution including "flow cytometer + reagents + software system + professional after-sales service"

More
Multi Cancer Detection Products
Multi Cancer Detection Products

Multi Cancer Detection Products

The product targets high incidence cancer and achieves early detection and treatment

More
Biochemical Products
Image Name

Biochemical Products

Learn More
Flow Cytometry Products
Image Name

Flow Cytometry Products

Learn More
Multi Cancer Detection Products
Image Name

Multi Cancer Detection Products

Learn More

Advantage

BIOSINO Advantages

Technological innovation and in-depth collaboration between industry, academia, and research

A publicly listed IVD R&D and manufacturing company,The company successfully listed on the Growth Enterprise Market of the Hong Kong Stock Exchange in 2006, one of the first IVD companies to be listed in China.

Owns completely independent intellectual property rights and invests approximately 10% of its total annual turnover in R&D.

Has a R&D team composed of numerous doctors and masters, establishing a "Postdoctoral Research Workstation" and jointly establishing a

"Center for In Vitro Diagnostic Engineering Research" with the Institute of Biophysics, Chinese Academy of Sciences,Recognized as the "Beijing Municipal Enterprise Technology Center".

Applied for and led the national "863 Plan" project "Key Biomedical Reagents" as the relying unit.

Has undertaken more than 10 national scientific and technological tasks, including the national "863 Plan," the National Science and Technology Support Plan, and the National High-tech Industry Demonstration Project.

Recognized as an "Innovative Enterprise" in the National Independent Innovation Demonstration Zone.

Explore More
1973 Year

Since

1988 Year

Company Founded

16000

Production Base

10 More Than

Participation in National-Level Projects

60 +

Global Layout

270 +

Registration Certificates

NEWS

News

Learn More about the latest News

Company News Company News Product Recommendations Product Recommendations Exhibition Express Exhibition Express
Explore More